Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner.
May 8, 2021
Copyright Nasdaq. Minimum 15 minutes delayed.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Events & Presentations
May 18, 2021 at 8:35 AM EDT
May 11, 2021 at 10:15 AM EDT
May 4, 2021 at 8:00 AM EDT